TrademarkDir
APICHOPE
LIVE

Serial Number

79393489

Owner

ApicHope Pharmaceutical Group Co.,Ltd

Attorney

Timothy T. Wang

Filing Date

Mar 6, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

APICHOPE Trademark

Serial Number: 79393489 • Registration: 7674341

APICHOPE is a trademark filed by ApicHope Pharmaceutical Group Co.,Ltd on March 6, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ApicHope Pharmaceutical Group Co.,Ltd

17/F Yunrun Building, No. 27 Huanyu 1st Road,

Entity Type: 03

ApicHope Pharmaceutical Co., Ltd

17/F Yunrun Building, No. 27 Huanyu 1st Road,

Entity Type: 99

Trademark Details

Filing Date

March 6, 2024

Registration Date

February 4, 2025

Published for Opposition

December 17, 2024

Goods & Services

Medicines for human purposes, for the treatment of infectious disease; medicines for human purposes, for the treatment of diabetes; medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; medicines for human purposes, for the treatment of hyperuricemia, gout; medicines for human purposes, for the treatment of autoimmune disorders; medicines for human purposes, for the treatment of cancer; medicines for human purposes, for the treatment of cardiovascular disease; medicines for human purposes for the treatment of respiratory system diseases; pharmaceutical preparations for the treatment of infectious disease; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; pharmaceutical preparations for the treatment of hyperuricemia, gout; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of respiratory system diseases

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 27, 2025 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2025 FINV
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 10, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 10, 2025 OPNR
GENERIC MADRID TRANSACTION SENT TO IB
Aug 18, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 18, 2025 XXCR
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 30, 2025 ADCH
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 4, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2024 NONP
REFUSAL PROCESSED BY IB
Oct 19, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 28, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 27, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 23, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 17, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 15, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2024 REPR

Related Trademarks